01 1Patheon Italia S.p.A.
02 1Uquifa Spain
01 1Hexyl Aminolevulinate Hydrochloride
02 1hexaminolevulinate hydrochloride
01 1Spain
02 1U.S.A
HEXAMINOLEVULINATE HYDROCHLORIDE
NDC Package Code : 68225-068
Start Marketing Date : 2010-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/50mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
HEXAMINOLEVULINATE HYDROCHLORIDE
NDC Package Code : 49711-1510
Start Marketing Date : 2009-10-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A HEXAMINOLEVULINATE HYDROCHLORIDE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of HEXAMINOLEVULINATE HYDROCHLORIDE, including repackagers and relabelers. The FDA regulates HEXAMINOLEVULINATE HYDROCHLORIDE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. HEXAMINOLEVULINATE HYDROCHLORIDE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of HEXAMINOLEVULINATE HYDROCHLORIDE manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A HEXAMINOLEVULINATE HYDROCHLORIDE supplier is an individual or a company that provides HEXAMINOLEVULINATE HYDROCHLORIDE active pharmaceutical ingredient (API) or HEXAMINOLEVULINATE HYDROCHLORIDE finished formulations upon request. The HEXAMINOLEVULINATE HYDROCHLORIDE suppliers may include HEXAMINOLEVULINATE HYDROCHLORIDE API manufacturers, exporters, distributors and traders.
click here to find a list of HEXAMINOLEVULINATE HYDROCHLORIDE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing HEXAMINOLEVULINATE HYDROCHLORIDE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for HEXAMINOLEVULINATE HYDROCHLORIDE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture HEXAMINOLEVULINATE HYDROCHLORIDE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain HEXAMINOLEVULINATE HYDROCHLORIDE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a HEXAMINOLEVULINATE HYDROCHLORIDE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of HEXAMINOLEVULINATE HYDROCHLORIDE suppliers with NDC on PharmaCompass.
LOOKING FOR A SUPPLIER?
